LIM homeobox protein 1 (LHX1)

LIM homeobox protein 1 (LHX1) is a member of the LIM homeobox gene family, characterized by a cysteine-rich LIM domain and a DNA-binding homeodomain. It functions as a transcription factor with critical roles in embryonic development, including specification and differentiation of neural and lymphoid cells, formation of head and female reproductive tract, renal organogenesis, and regulation of neuronal communication for circadian rhythm control. Dysregulation, deletion, or mutation of LHX1 is implicated in developmental disorders such as MRKH and 17q12 deletion syndrome, and aberrant LHX1 expression acts as an oncogene in renal cancers and promotes metastatic spread, making it a proposed—but currently unapproved—therapeutic target in oncology.

Other names

LIM homeobox 1LIM/homeobox protein Lhx1LIM-1LIM1hLim-1Homeobox protein Lim-1

Mechanisms under investigation include gene silencing (RNAi, siRNA), antibody-based targeting; therapeutic aim is to inhibit LHX1 transcriptional activity for cancer treatment. Mechanisms involve blockade of oncogenic and angiogenic signaling pathways regulated by LHX1 (PI3K/Akt, MAPK, NK-κB), inhibition of metastatic protein expression (e.g. paxillin, tenascin-C).